Literature DB >> 2736245

Circadian rhythm of erythropoietin in human serum.

L Wide1, C Bengtsson, G Birgegård.   

Abstract

When a sensitive radioimmunoassay for erythropoietin in serum (S-Epo), using labelled recombinant hEpo and antiserum to urinary hEpo, was evaluated for clinical use, a large intra-individual variation was observed during a 24 h period. The possibility of a circadian rhythm with a variation during day time which has to be considered for clinical evaluation of the S-Epo level was investigated in 27 hospitalized adult patients. They had various illnesses, but all had a level of S-Epo at 08.00 or 12.00 hours within the reference range of healthy individuals and normal cortisol levels during the 24 h. A well-marked circadian rhythm of S-Epo was found with the lowest mean level at 08.00 hours, a 42% increase at 16.00 hours and a 60% increase to the highest at 20.00 hours. Twelve (44%) of the 27 patients, with S-Epo levels within the reference range (3.3-13.5 IU/l) at 08.00 or 12.00 hours, had levels above this range at 16.00 hours. For clinical evaluation of the S-Epo level, the time of day for collection of the blood specimen has to be taken into consideration. It is recommended that blood specimens are taken in the morning between 07.30 and 12.00 hours. The mechanisms behind the observed circadian rhythm of S-Epo are unknown.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736245     DOI: 10.1111/j.1365-2141.1989.tb07657.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  33 in total

Review 1.  Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Authors:  Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Francoise Bressolle
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.

Authors:  Akashi Togawa; Takanori Tanaka; Satoru Nagashima; Hiroyuki Keta; Yasue Kobayashi; Yasuhiro Nishikawa; Masanobu Yanai; Hideji Tanaka
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

3.  Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.

Authors:  Per Olsson-Gisleskog; Philippe Jacqmin; Juan Jose Perez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

5.  Gene profiling the response to repeated cocaine self-administration in dorsal striatum: a focus on circadian genes.

Authors:  Wendy J Lynch; Matthew J Girgenti; Florence J Breslin; Samuel S Newton; Jane R Taylor
Journal:  Brain Res       Date:  2008-03-15       Impact factor: 3.252

Review 6.  Oxygen delivery enhancers: past, present, and future.

Authors:  P Borrione; A Mastrone; R A Salvo; A Spaccamiglio; L Grasso; A Angeli
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

7.  Cerebellar hemangioblastoma presenting as secondary erythrocytosis and aspiration pneumonia.

Authors:  H M Farrukh
Journal:  West J Med       Date:  1996-02

8.  Relationship between renal anemia and prognostic stages of IgA nephropathy.

Authors:  Seiki Aruga; Tomohide Horiuchi; Ichiyu Shou; Kyouichi Tashiro; Atsushi Kurusu; Mitsumine Fukui; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

9.  Regulation of clock-controlled genes in mammals.

Authors:  Katarzyna Bozek; Angela Relógio; Szymon M Kielbasa; Markus Heine; Christof Dame; Achim Kramer; Hanspeter Herzel
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

10.  Diurnal variations of serum erythropoietin at sea level and altitude.

Authors:  T Klausen; T D Poulsen; N Fogh-Andersen; J P Richalet; O J Nielsen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.